SAN DIEGO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares in effort to recover losses.

Investors, who purchased shares in excess of $100,000 of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between March 17, 2022 and June 20, 2023, have certain options and there are short and strict deadlines running. Deadline: September 29, 2023. Those NASDAQ: ALDX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On July 31, 2023, a lawsuit was filed by an investor in NASDAQ: ALDX against Aldeyra Therapeutics, Inc. over alleged Securities Laws Violations. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the ADX-2191 NDA did not include adequate and well-controlled investigations and thus failed to show substantial evidence of ADX-2191's effectiveness, that as a result, the FDA was unlikely to approve the ADX-2191 NDA in its current form, that accordingly, the Company had overstated ADX-2191's clinical and/or commercial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
mail@shareholdersfoundation.com 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.